Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Frontiers in Oncology|December 5, 2019
Assessment of Immune Response Following Dendritic Cell-Based Immunotherapy in Pediatric Patients With Relapsing SarcomaLenka Fedorova, Peter Mudry, Katerina Pilatova, et al.Therapeutic Advances in Medical Oncology|January 17, 2022
PET/CT-tailored treatment of locally advanced oesophago-gastric junction adenocarcinoma: a report on the feasibility of the multicenter GastroPET studyRadka Obermannova, Iveta Selingerova, Zdenek Rehak, et al.Therapeutic Advances in Medical Oncology|May 19, 2025
Patterns of SARS-CoV-2-specific humoral and cellular immune response in actively treated patients with solid cancer following prime BNT162b2 COVID-19 vaccination: results from phase IV CoVigi trialRadka Lordick Obermannova, Iveta Selingerova, Regina Demlova, et al.Frontiers in Oncology|November 12, 2019
Dendritic Cell-Based Immunotherapy in Advanced Sarcoma and Neuroblastoma Pediatric Patients: Anti-cancer Treatment Preceding Monocyte Harvest Impairs the Immunostimulatory and Antigen-Presenting Behavior of DCs and Manufacturing Process OutcomeEva Hlavackova, Katerina Pilatova, Dasa Cerna, et al.Frontiers in Medicine|January 23, 2024
Emergency medicine pharmacotherapy compromises accuracy of plasma creatinine determination by enzyme-based methods: real-world clinical evidence and implications for clinical practiceRegina Demlova, Sarka Kozakova, Michal Rihacek, et al.Gynecologic Oncology|June 19, 2015
A novel diagnostic index combining HE4, CA125 and age may improve triage of women with suspected ovarian cancer - An international multicenter study in women with an ovarian massMona A Karlsen, Estrid V S Høgdall, Ib J Christensen, et al.International Journal of Cancer|July 3, 2024
Personalized dendritic cell vaccine in multimodal individualized combination therapy improves survival in high-risk pediatric cancer patientsMichal Kyr, Peter Mudry, Kristyna Polaskova, et al.Frontiers in Oncology|March 3, 2020
Comprehensive Molecular Profiling for Relapsed/Refractory Pediatric Burkitt Lymphomas-Retrospective Analysis of Three Real-Life Clinical Cases-Addressing Issues on Randomization and Customization at the BedsideKristyna Polaskova, Tomas Merta, Alexandra Martincekova, et al.Pageof 3